Title : Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: results of the IMPACT-SHPT study.

Pub. Date : 2014 Apr

PMID : 24500308






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Levels of FGF-23 were increased with paricalcitol versus cinacalcet-centred treatment. Cinacalcet fibroblast growth factor 23 Homo sapiens